Key result
A 1-unit increment in the Triglyceride-glucose index was associated with an 18% higher risk of major adverse cardiac and cerebrovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Why the study?
The triglyceride-glucose index, a surrogate marker of insulin resistance, could be a potential prognostic marker in acute coronary syndrome patients.
Does a higher Triglyceride-glucose index predict major adverse cardiac and cerebrovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Cohort (n=13,542)
No
Does a higher Triglyceride-glucose index predict major adverse cardiac and cerebrovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
A higher Triglyceride-glucose index is an independent predictor of major adverse cardiac and cerebrovascular events in patients with acute coronary syndrome undergoing PCI, though this association is not significant in euglycemic patients.
BACKGROUND: Triglyceride-glucose index (TyG), a surrogate marker of insulin resistance (IR), could be a potential prognostic marker in patients with acute coronary syndromes (ACS). We evaluated the effect of the TyG index on major adverse cardiac and cerebrovascular events (MACCE) in patients with ACS undergoing percutaneous coronary intervention (PCI). METHODS: This registry-based cohort study was conducted at Tehran Heart Center from 2015 to 2021 and the median follow-up duration was 378 days. The primary outcome was MACCE and the secondary outcomes were MACCE components: all-cause mortality, myocardial infarction, stroke, target vessel revascularization, target lesion revascularization, and coronary artery bypass grafting. For comparison among TyG quartiles (Q), the log-rank test was used. Unadjusted and adjusted hazard ratios (HRs) and their 95% confidence intervals (CIs) were used to describe the association between TyG quartiles and MACCE. A subgroup of euglycemic patients was also evaluated. RESULTS: A total of 13,542 patients were included. Patients in the fourth TyG quartile (Q4) were younger, had higher mean BMI, and higher prevalence of hypertension, diabetes, and dyslipidemia. The adjusted Cox model showed that a 1-unit increment of the TyG index was associated with a significantly higher risk of MACCE (aHR 1.18, 95% CI 1.08 to 1.30, p < 0.001). Among TyG quartiles, there was a higher MACCE incidence in Q4 compared to Q1 (aHR 1.29, 95% CI 1.08 to 1.53, p = 0.005). In the euglycemic subgroup of the population, there was no significant association between MACCE incidence and a 1-unit increase in TyG or among TyG quartiles. CONCLUSION: Based on our findings, while higher TyG levels and quartiles were associated with higher rates of MACCE in ACS, there was no such effect in the euglycemic population. If confirmed in future studies, these results can be beneficial for clinicians to risk stratify these patients with an easy-to-use index and determine clinical plans based on their risk.
No takes yet. Share an insight, caveat, or question.
Khalaji et al. (2024) conducted a cohort in Acute coronary syndrome (n=13,542). Triglyceride-glucose (TyG) index vs. Lower TyG index was evaluated on Major adverse cardiac and cerebrovascular events (MACCE) (aHR 1.18, 95% CI 1.08-1.30, p=<0.001). A 1-unit increment in the Triglyceride-glucose index was associated with an 18% higher risk of major adverse cardiac and cerebrovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: